Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 3

NCT02319005

ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amy…

The purpose of this study was to evaluate the safety and efficacy of revusiran (ALN-TTRSC) in patients with transthyretin (TTR) mediated Familial Amyloidotic Ca…

United States206 participantsStarted 2014-12

Treatment: Revusiran (ALN-TTRSC), Sterile Normal Saline (0.9% NaCl)